[22] B 12 deficiency in pregnant women is increasingly common [23] and has been shown to be associated with major maternal health implications, including increased obesity, [23] higher body mass index (BMI), [24] insulin resistance, [22] gestational diabetes, and type 2 diabetes (T2D) in later life
however, no dose adjustments are needed based on renal function
The Melbourne-based company, which does not manufacture the drug, claims it is a potential treatment for cartilage and muscle damage and even osteoarthritis, though there is absolutely no clinical evidence of that
BPC 157 is usually positioned as a repair-focused peptide with strong interest around tendons, ligaments, muscle injury, and gut support
The application of NICE guidelines outside of England varies: Scotland, Wales, and Northern Ireland: These parts of the UK have their own guideline development bodies (SIGN, TGCS, and BSG, respectively)